329 related articles for article (PubMed ID: 30205044)
1. Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups.
Archer TC; Ehrenberger T; Mundt F; Gold MP; Krug K; Mah CK; Mahoney EL; Daniel CJ; LeNail A; Ramamoorthy D; Mertins P; Mani DR; Zhang H; Gillette MA; Clauser K; Noble M; Tang LC; Pierre-François J; Silterra J; Jensen J; Tamayo P; Korshunov A; Pfister SM; Kool M; Northcott PA; Sears RC; Lipton JO; Carr SA; Mesirov JP; Pomeroy SL; Fraenkel E
Cancer Cell; 2018 Sep; 34(3):396-410.e8. PubMed ID: 30205044
[TBL] [Abstract][Full Text] [Related]
2. Identification of Two Protein-Signaling States Delineating Transcriptionally Heterogeneous Human Medulloblastoma.
Zomerman WW; Plasschaert SLA; Conroy S; Scherpen FJ; Meeuwsen-de Boer TGJ; Lourens HJ; Guerrero Llobet S; Smit MJ; Slagter-Menkema L; Seitz A; Gidding CEM; Hulleman E; Wesseling P; Meijer L; van Kempen LC; van den Berg A; Warmerdam DO; Kruyt FAE; Foijer F; van Vugt MATM; den Dunnen WFA; Hoving EW; Guryev V; de Bont ESJM; Bruggeman SWM
Cell Rep; 2018 Mar; 22(12):3206-3216. PubMed ID: 29562177
[TBL] [Abstract][Full Text] [Related]
3. Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.
Forget A; Martignetti L; Puget S; Calzone L; Brabetz S; Picard D; Montagud A; Liva S; Sta A; Dingli F; Arras G; Rivera J; Loew D; Besnard A; Lacombe J; Pagès M; Varlet P; Dufour C; Yu H; Mercier AL; Indersie E; Chivet A; Leboucher S; Sieber L; Beccaria K; Gombert M; Meyer FD; Qin N; Bartl J; Chavez L; Okonechnikov K; Sharma T; Thatikonda V; Bourdeaut F; Pouponnot C; Ramaswamy V; Korshunov A; Borkhardt A; Reifenberger G; Poullet P; Taylor MD; Kool M; Pfister SM; Kawauchi D; Barillot E; Remke M; Ayrault O
Cancer Cell; 2018 Sep; 34(3):379-395.e7. PubMed ID: 30205043
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort.
Pietsch T; Schmidt R; Remke M; Korshunov A; Hovestadt V; Jones DT; Felsberg J; Kaulich K; Goschzik T; Kool M; Northcott PA; von Hoff K; von Bueren AO; Friedrich C; Mynarek M; Skladny H; Fleischhack G; Taylor MD; Cremer F; Lichter P; Faldum A; Reifenberger G; Rutkowski S; Pfister SM
Acta Neuropathol; 2014 Jul; 128(1):137-49. PubMed ID: 24791927
[TBL] [Abstract][Full Text] [Related]
5. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
[TBL] [Abstract][Full Text] [Related]
6. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.
Remke M; Hielscher T; Korshunov A; Northcott PA; Bender S; Kool M; Westermann F; Benner A; Cin H; Ryzhova M; Sturm D; Witt H; Haag D; Toedt G; Wittmann A; Schöttler A; von Bueren AO; von Deimling A; Rutkowski S; Scheurlen W; Kulozik AE; Taylor MD; Lichter P; Pfister SM
J Clin Oncol; 2011 Oct; 29(29):3852-61. PubMed ID: 21911727
[TBL] [Abstract][Full Text] [Related]
7. Proteomic profiling of high risk medulloblastoma reveals functional biology.
Staal JA; Lau LS; Zhang H; Ingram WJ; Hallahan AR; Northcott PA; Pfister SM; Wechsler-Reya RJ; Rusert JM; Taylor MD; Cho YJ; Packer RJ; Brown KJ; Rood BR
Oncotarget; 2015 Jun; 6(16):14584-95. PubMed ID: 25970789
[TBL] [Abstract][Full Text] [Related]
8. Multiple DNA damage-dependent and DNA damage-independent stress responses define the outcome of ATR/Chk1 targeting in medulloblastoma cells.
Krüger K; Geist K; Stuhldreier F; Schumacher L; Blümel L; Remke M; Wesselborg S; Stork B; Klöcker N; Bormann S; Roos WP; Honnen S; Fritz G
Cancer Lett; 2018 Aug; 430():34-46. PubMed ID: 29753759
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of genomic aberrations during clinical progression of medulloblastoma.
Korshunov A; Benner A; Remke M; Lichter P; von Deimling A; Pfister S
Acta Neuropathol; 2008 Oct; 116(4):383-90. PubMed ID: 18704466
[TBL] [Abstract][Full Text] [Related]
10. Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells.
Wang X; Venugopal C; Manoranjan B; McFarlane N; O'Farrell E; Nolte S; Gunnarsson T; Hollenberg R; Kwiecien J; Northcott P; Taylor MD; Hawkins C; Singh SK
Oncogene; 2012 Jan; 31(2):187-99. PubMed ID: 21685941
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of human Sonic Hedgehog (SHH) medulloblastoma stem-like cells.
Ronci M; Catanzaro G; Pieroni L; Po A; Besharat ZM; Greco V; Levi Mortera S; Screpanti I; Ferretti E; Urbani A
Mol Biosyst; 2015 Jun; 11(6):1603-11. PubMed ID: 25756958
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of Medulloblastoma reveals functional biology with translational potential.
Rivero-Hinojosa S; Lau LS; Stampar M; Staal J; Zhang H; Gordish-Dressman H; Northcott PA; Pfister SM; Taylor MD; Brown KJ; Rood BR
Acta Neuropathol Commun; 2018 Jun; 6(1):48. PubMed ID: 29880060
[TBL] [Abstract][Full Text] [Related]
13. A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma.
Conduit SE; Ramaswamy V; Remke M; Watkins DN; Wainwright BJ; Taylor MD; Mitchell CA; Dyson JM
Oncogene; 2017 Oct; 36(43):5969-5984. PubMed ID: 28650469
[TBL] [Abstract][Full Text] [Related]
14. SNCA, a novel biomarker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosis.
Li YX; Yu ZW; Jiang T; Shao LW; Liu Y; Li N; Wu YF; Zheng C; Wu XY; Zhang M; Zheng DF; Qi XL; Ding M; Zhang J; Chang Q
Cancer Sci; 2018 Apr; 109(4):1263-1275. PubMed ID: 29369502
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells.
Huang A; Ho CS; Ponzielli R; Barsyte-Lovejoy D; Bouffet E; Picard D; Hawkins CE; Penn LZ
Cancer Res; 2005 Jul; 65(13):5607-19. PubMed ID: 15994933
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis suppression by somatic cell transfer of Bcl-2 promotes Sonic hedgehog-dependent medulloblastoma formation in mice.
McCall TD; Pedone CA; Fults DW
Cancer Res; 2007 Jun; 67(11):5179-85. PubMed ID: 17545597
[TBL] [Abstract][Full Text] [Related]
17. Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children.
Triscott J; Lee C; Foster C; Manoranjan B; Pambid MR; Berns R; Fotovati A; Venugopal C; O'Halloran K; Narendran A; Hawkins C; Ramaswamy V; Bouffet E; Taylor MD; Singhal A; Hukin J; Rassekh R; Yip S; Northcott P; Singh SK; Dunham C; Dunn SE
Cancer Res; 2013 Nov; 73(22):6734-44. PubMed ID: 24019381
[TBL] [Abstract][Full Text] [Related]
18. Clustering of self-organizing map identifies five distinct medulloblastoma subgroups.
Cao C; Wang W; Jiang P
Cancer Biomark; 2016; 16(3):327-32. PubMed ID: 26889815
[TBL] [Abstract][Full Text] [Related]
19. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.
Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK
BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958
[TBL] [Abstract][Full Text] [Related]
20. Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progression.
Thomas WD; Chen J; Gao YR; Cheung B; Koach J; Sekyere E; Norris MD; Haber M; Ellis T; Wainwright B; Marshall GM
Oncogene; 2009 Apr; 28(13):1605-15. PubMed ID: 19234491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
